VIJAYA.NS Profit & Loss
Vijaya Diagnostic Centre Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 01:45
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹4.59 Bn | ₹5.48 Bn | ₹6.81 Bn | ₹8.14 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹0.14 Bn | ₹0.21 Bn | ₹0.18 Bn | ₹0.21 Bn | OtherIncome |
| Total Income | ₹4.73 Bn | ₹5.69 Bn | ₹7.00 Bn | ₹8.35 Bn | Income |
| Cost of Materials Consumed | ₹0.59 Bn | ₹0.65 Bn | ₹0.85 Bn | ₹0.95 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹0.78 Bn | ₹0.90 Bn | ₹1.12 Bn | ₹1.31 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹0.21 Bn | ₹0.24 Bn | ₹0.27 Bn | ₹0.33 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹0.62 Bn | ₹0.57 Bn | ₹0.71 Bn | ₹0.92 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹1.40 Bn | ₹1.71 Bn | ₹2.11 Bn | ₹2.52 Bn | OtherExpenses |
| Total Expenses | ₹3.60 Bn | ₹4.08 Bn | ₹5.06 Bn | ₹6.02 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹1.14 Bn | ₹1.61 Bn | ₹1.94 Bn | ₹2.33 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Bn | ₹-0.02 Bn | ₹-0.01 Bn | ₹0.00 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹1.14 Bn | ₹1.59 Bn | ₹1.93 Bn | ₹2.33 Bn | ProfitBeforeTax |
| Tax Expense | ₹0.28 Bn | ₹0.39 Bn | ₹0.49 Bn | ₹0.60 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹0.85 Bn | ₹1.20 Bn | ₹1.44 Bn | ₹1.73 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹0.85 Bn | ₹1.19 Bn | ₹1.43 Bn | ₹1.73 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹8.29 | ₹11.62 | ₹13.95 | ₹16.81 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹8.26 | ₹11.59 | ₹13.92 | ₹16.79 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from VIJAYA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).